Addex to Present at the Swiss Biotech Day 2024 : vimarsana.c

Geneva, Switzerland, April 19, 2024 - Addex Therapeutics , a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug development, announced today that CEO, Tim Dyer, will...

Related Keywords

Switzerland , United States , Geneva , Genè , American , Swiss , Mike Sinclair , Tim Dyer , Janssen Pharmaceuticals Inc , Congress Center , Swiss Exchange , Nasdaq , Swiss Biotech Day , Addex Therapeutics , Janssen Pharmaceuticals , American Depositary Shares , Executive Officer , Halsin Partners , Forward Looking Statements , Private Securities Litigation Reform Act , Addex Therapeutic Annual Report , Addex Therapeutic , Markets ,